Literature DB >> 21757957

Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years.

Fabrizio Pallaver1, Anna Pia Riviera, Silvano Piffer, Roberta Ricciardi, Riccardo Roni, Daniele Orrico, Domenico Marco Bonifati.   

Abstract

BACKGROUND: The recent literature suggests that the incidence and prevalence of myasthenia gravis (MG) are changing. We performed a population-based study of MG in the province of Trentino (524,826 inhabitants) and compared the results with those collected 20 years ago.
METHODS: Multiple sources of information (discharge diagnosis, antibody tests and anticholinesterase drugs) were analyzed. Incidence was calculated from 2005 to 2009. Prevalence was calculated on December 31, 2009. Comparison was made with descriptive statistics for 1981-1990 for the identical region.
RESULTS: Incidence and prevalence greatly increased in comparison with 1981-1990 data. The prevalence rate increased from 82.9 (95% confidence interval, CI, 58.4-114.3) in 1990 to 129.6 (95% CI 100.6-164.3) per million population, whereas the average annual incidence increased from 7.4 (95% CI 5-10.4) per million person-years in 1981-1990 to 14.8 (95% CI 10.5-20.3) in 2005-2009. This increase was mainly due to male patients with late-onset MG.
CONCLUSIONS: The study confirms the increase in incidence and prevalence of late-onset MG in the same region 20 years apart. So we should consider MG also as a disease of the elderly.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21757957     DOI: 10.1159/000328863

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  6 in total

Review 1.  Myasthenia gravis: an update for the clinician.

Authors:  J P Sieb
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

2.  Incidence and Prevalence of Myasthenia Gravis in Korea: A Population-Based Study Using the National Health Insurance Claims Database.

Authors:  Su Yeon Park; Jin Yong Lee; Nam Gu Lim; Yoon Ho Hong
Journal:  J Clin Neurol       Date:  2016-05-10       Impact factor: 3.077

Review 3.  The epidemiology of myasthenia gravis.

Authors:  Ana-Maria Bubuioc; Aigerim Kudebayeva; Saule Turuspekova; Vitalie Lisnic; Maurizio Angelo Leone
Journal:  J Med Life       Date:  2021 Jan-Mar

4.  Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data.

Authors:  Iain M Carey; Emma Banchoff; Niranjanan Nirmalananthan; Tess Harris; Stephen DeWilde; Umar A R Chaudhry; Derek G Cook
Journal:  PLoS One       Date:  2021-12-31       Impact factor: 3.240

5.  Association of HLA-DQB1∗05:02 and DRB1∗16 Alleles with Late-Onset, Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis.

Authors:  Manuela Testi; Chiara Terracciano; Annalisa Guagnano; Giuseppe Testa; Girolama A Marfia; Eugenio Pompeo; Marco Andreani; Roberto Massa
Journal:  Autoimmune Dis       Date:  2012-10-09

6.  Epidemiology of Myasthenia Gravis in Sweden 2006-2016.

Authors:  Elisabet Westerberg; Anna Rostedt Punga
Journal:  Brain Behav       Date:  2020-09-01       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.